← SynDRA
FOSPHENYTOIN
SynDRA canonical compound SYN0023543 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | CYP2C19 | SCN1A | SCN3A | SCN5A |
|---|
| Mechanism of action | sodium channel blocker |
|---|
| Indication | epilepsy | seizures |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- SCN5A
- SCN1A
- SCN3A
- CYP2C19
- SCN10A
- SCN11A
- SCN2A
- SCN4A
- SCN7A
- SCN8A
- SCN9A
Mechanisms of action (all sources)
- SCN1A BLOCKER
- Sodium channel alpha subunit blocker
- SCN5A BLOCKER
- SCN4A BLOCKER
- SCN7A BLOCKER
- SCN2A BLOCKER
- SCN9A BLOCKER
- SCN3A BLOCKER
- SCN11A BLOCKER
- SCN8A BLOCKER
- SCN10A BLOCKER
- sodium channel blocker
Drug classes
- Anticonvulsants
- Cardiovascular Agents
- Central Nervous System Agents
- Membrane Transport Modulators
- Sodium Channel Blockers
- Anti-epileptic Agent
ATC classes
Cross-references
Synonyms
- cerebyx
- fosphenytoin sodium
- fosphenytoin sodium hydrate
- Fosphenytoine
- Fosfenitoina
- Np-06
- Fosphenytoinum
- HMPDP
- Prodilantin
- ACC-9653
- Cerebyx (TN)
- Fosfenitoina [INN-Spanish]
- Fosphenytoin (INN)
- Fosphenytoin [INN:BAN]
- Fosphenytoine [INN-French]
- Fosphenytoinum [INN-Latin]
- Prodilantin (TN)
- (2,5-dioxo-4,4-diphenylimidazolidin-1-yl)methyl dihydrogen phosphate
- (3-Phosphoryloxymethyl)phenytoin
- 3-(hydroxymethyl)phenytoin disodium phosphate
- 3-(hydroxymethyl)phenytoin phosphate ester
- NP-06
- B4SF212641
- ACC 9653
- DTXCID7024299
- RefChem:141396
- N03AB05
- Cerebyx
- FOSPHENYTOIN [INN]
- UNII-B4SF212641
- HSDB 7523
- FOSPHENYTOIN [MI]
- FOSPHENYTOIN [HSDB]
- FOSPHENYTOIN [VANDF]
- SCHEMBL94254
- BIDD:GT0220
- FOSPHENYTOIN [WHO-DD]
- CHEBI:5165
Look up FOSPHENYTOIN in the interactive SynDRA portal →